Literature DB >> 9246674

Leptin levels in patients with anorexia nervosa are reduced in the acute stage and elevated upon short-term weight restoration.

J Hebebrand1, W F Blum, N Barth, H Coners, P Englaro, A Juul, A Ziegler, A Warnke, W Rascher, H Remschmidt.   

Abstract

Circulating leptin concentrations are known to be low in acute anorexia nervosa (AN), which is characterized by low weight, amenorrhea and specific psychopathological features. In this study plasma leptin concentrations were determined during inpatient treatment of 23 adolescent females with AN using a sensitive radioimmunoassay (RIA) and set into relationship to leptin levels of females matched for age, body mass index (BMI; kg m-2) and/or percent body fat. At referral patients had leptin concentrations well below the female controls. Weight gains led to steep increases of leptin levels which peaked at values well in excess of those observed in controls matched for BMI. In patients who reached the final treatment stage and who were followed-up after discharge, levels subsequently fluctuated and finally dropped into or below the control range. The low leptin levels at referral are likely to be involved in the pathogenesis of amenorrhea and the reduced metabolic state of acutely ill patients. Peak leptin levels reached after weight gain are possibly the cause of increased energy expenditure during this stage of the disorder.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246674     DOI: 10.1038/sj.mp.4000282

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  32 in total

1.  Predictors of menstrual resumption by patients with anorexia nervosa.

Authors:  C Arimura; T Nozaki; S Takakura; K Kawai; M Takii; N Sudo; C Kubo
Journal:  Eat Weight Disord       Date:  2010-05-10       Impact factor: 4.652

2.  Correlation between psychometric and biological parameters in anorexic and bulimic patients during and after an intensive day hospital treatment.

Authors:  F Manara; A Manara; P Todisco
Journal:  Eat Weight Disord       Date:  2005-12       Impact factor: 4.652

Review 3.  Relevance of animal models to human eating disorders and obesity.

Authors:  Regina C Casper; Elinor L Sullivan; Laurence Tecott
Journal:  Psychopharmacology (Berl)       Date:  2008-03-04       Impact factor: 4.530

Review 4.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

Review 5.  Genetics of eating disorders.

Authors:  Anke Hinney; Anna-Lena Volckmar
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

Review 6.  The endocrine manifestations of anorexia nervosa: mechanisms and management.

Authors:  Melanie Schorr; Karen K Miller
Journal:  Nat Rev Endocrinol       Date:  2016-11-04       Impact factor: 43.330

Review 7.  Examining weight suppression as a transdiagnostic factor influencing illness trajectory in bulimic eating disorders.

Authors:  Pamela K Keel; Lindsay P Bodell; K Jean Forney; Jonathan Appelbaum; Diana Williams
Journal:  Physiol Behav       Date:  2019-05-30

8.  Cannabinoid CB1 /CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia.

Authors:  Maria Scherma; Valentina Satta; Roberto Collu; Maria Francesca Boi; Paolo Usai; Walter Fratta; Paola Fadda
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

9.  Appetite regulatory hormones in women with anorexia nervosa: binge-eating/purging versus restricting type.

Authors:  Kamryn T Eddy; Elizabeth A Lawson; Christina Meade; Erinne Meenaghan; Sarah E Horton; Madhusmita Misra; Anne Klibanski; Karen K Miller
Journal:  J Clin Psychiatry       Date:  2015-01       Impact factor: 4.384

Review 10.  Eating disorders: the current status of molecular genetic research.

Authors:  Susann Scherag; Johannes Hebebrand; Anke Hinney
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-12-24       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.